Towards early diagnosis of Alzheimer's disease: Advances in immune-related blood biomarkers and computational modeling approaches

• URL: http://arxiv.org/abs/2312.02248v2
• Date: Wed, 6 Dec 2023 10:05:42 GMT
• Title: Towards early diagnosis of Alzheimer's disease: Advances in immune-related blood biomarkers and computational modeling approaches
• Authors: Sophia Krix, Ella Wilczynski, Neus Falg\`as, Raquel S\'anchez-Valle, Eti Yoles, Uri Nevo, Kuti Baruch, Holger Fr\"ohlich
• Abstract summary: Alzheimer's disease is usually diagnosed late, which contrasts with the currently available treatment options. We give a background on advances in research on brain-immune system cross-talk in Alzheimer's disease. We review recent machine learning and mechanistic modeling approaches which leverage modern omics technologies for blood-based immune system-related biomarker discovery.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Alzheimer's disease has an increasing prevalence in the population world-wide, yet current diagnostic methods based on recommended biomarkers are only available in specialized clinics. Due to these circumstances, Alzheimer's disease is usually diagnosed late, which contrasts with the currently available treatment options that are only effective for patients at an early stage. Blood-based biomarkers could fill in the gap of easily accessible and low-cost methods for early diagnosis of the disease. In particular, immune-based blood-biomarkers might be a promising option, given the recently discovered cross-talk of immune cells of the central nervous system with those in the peripheral immune system. With the help of machine learning algorithms and mechanistic modeling approaches, such as agent-based modeling, an in-depth analysis of the simulation of cell dynamics is possible as well as of high-dimensional omics resources indicative of pathway signaling changes. Here, we give a background on advances in research on brain-immune system cross-talk in Alzheimer's disease and review recent machine learning and mechanistic modeling approaches which leverage modern omics technologies for blood-based immune system-related biomarker discovery.

Related papers

• Statistical testing on generative AI anomaly detection tools in Alzheimer's Disease diagnosis [16.73336092521471]
  generative AI has shown promise in anomaly detection in medical imaging. We propose to solve this issue with selective inference and develop a reliable generative AI method for Alzheimer's prediction.
  arXiv  Detail & Related papers  (2024-10-17T09:15:09Z)
• MMIL: A novel algorithm for disease associated cell type discovery [58.044870442206914]
  Single-cell datasets often lack individual cell labels, making it challenging to identify cells associated with disease. We introduce Mixture Modeling for Multiple Learning Instance (MMIL), an expectation method that enables the training and calibration of cell-level classifiers.
  arXiv  Detail & Related papers  (2024-06-12T15:22:56Z)
• A Survey of Artificial Intelligence in Gait-Based Neurodegenerative Disease Diagnosis [51.07114445705692]
  neurodegenerative diseases (NDs) traditionally require extensive healthcare resources and human effort for medical diagnosis and monitoring. As a crucial disease-related motor symptom, human gait can be exploited to characterize different NDs. The current advances in artificial intelligence (AI) models enable automatic gait analysis for NDs identification and classification.
  arXiv  Detail & Related papers  (2024-05-21T06:44:40Z)
• Machine Learning Classification of Alzheimer's Disease Stages Using Cerebrospinal Fluid Biomarkers Alone [0.3277163122167434]
  Early diagnosis of Alzheimer's disease is a challenge because the existing methodologies do not identify the patients in their preclinical stage. Several research studies demonstrate the potential of cerebrospinal fluid biomarkers, amyloid beta 1-42, T-tau, and P-tau, in early diagnosis of Alzheimer's disease stages. We used machine learning models to classify different stages of Alzheimer's disease based on the cerebrospinal fluid biomarker levels alone.
  arXiv  Detail & Related papers  (2024-01-02T00:55:10Z)
• Single-Cell Deep Clustering Method Assisted by Exogenous Gene Information: A Novel Approach to Identifying Cell Types [50.55583697209676]
  We develop an attention-enhanced graph autoencoder, which is designed to efficiently capture the topological features between cells. During the clustering process, we integrated both sets of information and reconstructed the features of both cells and genes to generate a discriminative representation. This research offers enhanced insights into the characteristics and distribution of cells, thereby laying the groundwork for early diagnosis and treatment of diseases.
  arXiv  Detail & Related papers  (2023-11-28T09:14:55Z)
• A marker-less human motion analysis system for motion-based biomarker discovery in knee disorders [60.99112047564336]
  The NHS has been having increased difficulty seeing all low-risk patients, this includes but not limited to suspected osteoarthritis (OA) patients. We propose a novel method of automated biomarker identification for diagnosis of knee disorders and the monitoring of treatment progression.
  arXiv  Detail & Related papers  (2023-04-26T16:47:42Z)
• LAVA: Granular Neuron-Level Explainable AI for Alzheimer's Disease Assessment from Fundus Images [15.02513291695459]
  Alzheimer's Disease (AD) is a progressive neurodegenerative disease and the leading cause of dementia. The retina has been hypothesized as a diagnostic site for AD detection owing to its anatomical connection with the brain. We propose a novel model-agnostic explainable-AI framework, called Granular Neuron-level Explainer (LAVA)
  arXiv  Detail & Related papers  (2023-02-06T18:43:10Z)
• Pathology Steered Stratification Network for Subtype Identification in Alzheimer's Disease [7.594681424335177]
  Alzheimers disease (AD) is a heterogeneous, multitemporal neurodegenerative disorder characterized by beta-amyloid, pathologic tau, and neurodegeneration. We propose a novel pathology steered stratification network (PSSN) that incorporates established domain knowledge in AD pathology through a reaction-diffusion model.
  arXiv  Detail & Related papers  (2022-10-12T02:52:00Z)
• Weakly-supervised learning for image-based classification of primary melanomas into genomic immune subgroups [1.4585861543119112]
  We develop deep learning models to classify gigapixel H&E stained pathology slides into immune subgroups. We leverage a multiple-instance learning approach, which only requires slide-level labels and uses an attention mechanism to highlight regions of high importance to the classification.
  arXiv  Detail & Related papers  (2022-02-23T13:57:35Z)
• MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
  This paper aims at a unified deep learning approach to predict patient prognosis and therapy response. We formalize the prognosis modeling as a multi-modal asynchronous time series classification task. Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
  arXiv  Detail & Related papers  (2020-10-08T15:30:17Z)
• A Graph Gaussian Embedding Method for Predicting Alzheimer's Disease Progression with MEG Brain Networks [59.15734147867412]
  Characterizing the subtle changes of functional brain networks associated with Alzheimer's disease (AD) is important for early diagnosis and prediction of disease progression. We developed a new deep learning method, termed multiple graph Gaussian embedding model (MG2G) We used MG2G to detect the intrinsic latent dimensionality of MEG brain networks, predict the progression of patients with mild cognitive impairment (MCI) to AD, and identify brain regions with network alterations related to MCI.
  arXiv  Detail & Related papers  (2020-05-08T02:29:24Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.